See more : Medicamen Biotech Limited (MEDICAMEQ.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Ameritrans Capital Corp. PFD PRT 9.375% (AMTPQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ameritrans Capital Corp. PFD PRT 9.375%, a leading company in the Asset Management industry within the Financial Services sector.
- Beamr Imaging Ltd. (BMR) Income Statement Analysis – Financial Results
- Holmen AB (publ) (HLMNY) Income Statement Analysis – Financial Results
- CJ Cheiljedang Corporation (097950.KS) Income Statement Analysis – Financial Results
- FFD Financial Corporation (FFDF) Income Statement Analysis – Financial Results
- The Westaim Corporation (WEDXF) Income Statement Analysis – Financial Results
Ameritrans Capital Corp. PFD PRT 9.375% (AMTPQ)
Industry: Asset Management
Sector: Financial Services
About Ameritrans Capital Corp. PFD PRT 9.375%
Ameritrans Capital Corp is a closed-end investment company. The company makes loans and investments with the goal of generating both current income and capital appreciation.
Metric | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 780.12K | 682.44K | 749.23K | -268.24K | 4.11M | 4.13M | 3.17M | 4.29M | 4.20M | 4.21M | 3.64M | 3.10M | 3.23M | 3.20M | 2.27M |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 780.12K | 682.44K | 749.23K | -268.24K | 4.11M | 4.13M | 3.17M | 4.29M | 4.20M | 4.21M | 3.64M | 3.10M | 3.23M | 3.20M | 2.27M |
Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 3.21M | 3.73M | 3.10M | 3.09M | 1.87M | 1.52M | 1.16M | 1.13M | 1.02M | 879.07K | 1.86M | 627.01K | 594.80K | 500.00K | 739.88K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 3.21M | 3.73M | 3.10M | 3.09M | 1.87M | 1.52M | 1.16M | 1.13M | 1.02M | 879.07K | 1.86M | 627.01K | 594.80K | 500.00K | 739.88K |
Other Expenses | -353.62K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 2.85M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost & Expenses | 2.85M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Income | 2.05M | 2.10M | 1.59M | 3.11M | 5.92M | 5.28M | 4.68M | 4.77M | 5.20M | 6.07M | 5.98M | 6.17M | 6.18M | 5.20M | 4.11M |
Interest Expense | 1.28M | 1.45M | 906.20K | 1.09M | 2.36M | 2.18M | 2.12M | 1.84M | 1.44M | 2.08M | 2.63M | 3.47M | 3.37M | 2.40M | 1.84M |
Depreciation & Amortization | 80.46K | 79.55K | 88.89K | 70.99K | 76.63K | 108.08K | 122.58K | 148.68K | 133.69K | 77.66K | 68.63K | 65.74K | 74.71K | 100.00K | 49.89K |
EBITDA | 0.00 | -5.72M | -6.29M | -5.38M | -460.94K | 6.86K | 0.00 | -415.63K | -193.03K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA Ratio | -689.84% | -838.61% | -839.00% | 2,009.92% | -11.22% | 3.48% | -2.72% | 6.27% | -5.17% | 11.42% | 30.67% | 20.90% | 9.31% | 40.63% | 43.54% |
Operating Income | -5.46M | -5.80M | -6.37M | -5.46M | -537.57K | 35.53K | -208.65K | 120.49K | -350.68K | 403.11K | 1.05M | 582.41K | 226.32K | 1.20M | 937.61K |
Operating Income Ratio | -700.16% | -850.27% | -850.86% | 2,036.38% | -13.09% | 0.86% | -6.59% | 2.81% | -8.36% | 9.58% | 28.79% | 18.78% | 7.00% | 37.50% | 41.34% |
Total Other Income/Expenses | 353.62K | 0.00 | -2.40M | -9.93K | 0.00 | 136.76K | -485.11K | 684.79K | -23.97K | 403.11K | 0.00 | 0.00 | 226.32K | -2.50M | 937.61K |
Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 35.53K | -208.65K | 120.49K | -350.68K | 403.11K | 1.05M | 582.41K | 226.32K | 0.00 | 937.61K |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.86% | -6.59% | 2.81% | -8.36% | 9.58% | 28.79% | 18.78% | 7.00% | 0.00% | 41.34% |
Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.25K | 10.03K | 7.71K | 16.50K | 7.90K | 8.85K | 7.90K | 13.57K | 0.00 | 3.27K |
Net Income | -5.46M | -5.80M | -6.37M | -5.46M | -537.57K | 33.28K | -218.68K | 112.77K | -367.18K | 395.21K | 1.04M | 574.51K | 212.75K | 1.20M | 934.34K |
Net Income Ratio | -700.16% | -850.27% | -850.86% | 2,036.38% | -13.09% | 0.81% | -6.90% | 2.63% | -8.75% | 9.39% | 28.55% | 18.52% | 6.58% | 37.50% | 41.20% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports